The PM Society Market Access Interest Group (MAIG) is gearing up to host its next in-person meeting on Tuesday, May 23rd, at the prestigious Royal Society of Medicine in London.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
